These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Etiopathogenesis of diabetic microangiopathy]. Schulz B; Zander E Z Arztl Fortbild (Jena); 1990; 84(21):1111-5. PubMed ID: 2281699 [No Abstract] [Full Text] [Related]
3. Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy. Yamagishi S; Takeuchi M; Inagaki Y; Nakamura K; Imaizumi T Int J Clin Pharmacol Res; 2003; 23(4):129-34. PubMed ID: 15224502 [TBL] [Abstract][Full Text] [Related]
4. [Diabetic microangiopathy]. García-Conde Gómez FJ An R Acad Nac Med (Madr); 1986; 103(2):173-89. PubMed ID: 3799953 [No Abstract] [Full Text] [Related]
5. [Physiopathology of chronic complications of diabetes]. Gomez F Rev Med Suisse Romande; 1993 Sep; 113(9):703-6. PubMed ID: 8210898 [No Abstract] [Full Text] [Related]
19. The Renin-Angiotensin system and vascular disease in diabetes. Deinum J; Chaturvedi N Semin Vasc Med; 2002 May; 2(2):149-56. PubMed ID: 16222606 [TBL] [Abstract][Full Text] [Related]
20. [Hypertension and diabetes: mechanisms of elevation of arterial pressure, physiopathologic basis of therapeutic antihypertensives]. Mogensen CE Journ Annu Diabetol Hotel Dieu; 1993; ():161-88. PubMed ID: 8331863 [No Abstract] [Full Text] [Related] [Next] [New Search]